Artelo Biosciences ARTL Cash Flow Statement (2014-2026)

NASDAQ ARTL
$2.18 +0.04 (+1.76%)
As of: Nov 11, 2026 · 3:59 PM EST
Reported Financials

Artelo Biosciences Quarterly Cash Flow Statement

Periods 50 quarters
Latest Jun 2026

Artelo Biosciences reported cash from operations of -$5.03M and free cash flow of -$5.03M for the quarter ended Jun 2026, down 879.2% year over year. This cash flow statement covers 50 quarters of results from Feb 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.26M-2.55M-1.97M-2.45M2.33M-16.83M-2.17M5.94M2.45M-15.51M-2.48M-2.43M10.96M3.78M-2.37M-3.22M14.31M4.17M-2.96M-2.43M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.05M0.08M-0.08M0.02M0.01M
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
0.57M0.62M0.62M0.61M0.61M0.35M0.23M0.22M0.22M0.21M0.20M0.21M0.20M0.19M0.15M0.43M0.37M0.40M0.57M
Gains from Investment SecuritiesGains Investment
0.00M0.02M-0.02M0.07M0.14M0.12M0.19M0.17M0.17M0.11M-0.29M-0.28M0.08M-0.01M0.15M
Other non-cash itemsOther Non-Cash
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.50M0.01M0.01M
Change in Working Capital
Change in Account PayablesChange Payables
0.02M0.01M-0.02M0.03M0.03M-0.04M0.00M-0.02M0.05M-0.04M-0.01M0.03M-0.04M0.00M0.01M0.31M0.12M-0.36M
Change in Accrued ExpensesChange Accrued Exp.
0.13M-0.16M-0.38M-0.02M0.55M-0.21M-0.19M0.33M0.37M-0.62M0.26M-0.26M1.08M0.80M2.25M-0.91M-0.83M1.03M-2.76M
Change in Other Operating AssetsOther Assets Change
-0.09M-0.59M0.92M-0.14M-0.39M0.07M-0.17M-0.26M-0.07M-0.01M-0.04M-0.48M0.06M0.42M-0.47M-0.05M-0.02M0.05M-0.13M
Change in Other Operating LiabilitiesOther Liabilities Change
0.03M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.02M-0.03M0.01M0.00M0.01M
Other Working Capital ChangesOther WC Changes
0.12M0.59M-0.94M0.13M0.38M-0.08M0.16M0.25M0.07M0.00M0.03M0.47M-0.07M-0.42M0.49M0.02M0.03M-0.06M0.15M
Cash from OperationsCash from Ops.
-1.93M-2.05M-1.97M-1.70M-2.29M-2.19M-1.62M-1.80M-2.60M-2.94M-2.06M-0.78M-2.57M-1.60M-0.51M-3.50M-2.91M-1.19M-5.03M
Investing Activities
Capital ExpendituresCapex
Change in Property, Plant and EquipmentChange in PP&E
Purchase of InvestmentsInvestments Purchased
2.45M0.74M7.86M2.18M5.80M2.35M4.58M0.95M0.48M
Sale and Maturity of InvestmentsInvestments Sold
12.64M2.70M12.15M-2.65M3.98M8.00M2.75M2.75M3.69M1.75M1.75M4.25M0.50M
Cash from Investing ActivitiesCash from Investing
-8.88M0.26M3.99M-3.08M1.80M2.20M0.40M-1.83M2.74M1.27M1.75M4.25M0.50M-0.25M0.19M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.74M-0.13M0.59M
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.74M-0.13M0.59M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.74M-0.13M0.59M
Change in Capital Stock
Common Stock IssuedStock Issued
18.26M0.54M0.03M0.06M0.06M1.08M3.44M1.76M10.27M-0.06M
Net Shares Issued and RepurchasedNet Shares Issued
18.26M0.54M0.03M0.06M0.06M1.08M3.44M1.76M10.27M-0.06M
Net Equity Issued and RepurchasedNet Equity Issued
18.26M0.54M0.03M0.06M0.06M1.08M3.44M1.76M10.27M-0.06M
Other financing activities (as filed)
-0.42M
Cash from Financing ActivitiesCash from Financing
18.26M-0.13M0.13M0.54M0.03M0.06M0.06M1.82M3.44M1.61M10.86M-1.06M
Additional items
Exchange Rate EffectFX Effect
-0.04M-0.02M-0.11M-0.21M0.12M0.02M0.03M0.02M0.00M0.00M0.00M0.00M-0.01M0.01M0.02M-0.04M0.00M0.00M0.02M
Change in Cash
7.42M-1.81M1.77M-4.99M-0.25M0.03M-1.20M-3.08M0.18M-1.62M-0.31M3.48M-2.02M-1.59M1.32M-0.35M-1.12M9.67M-6.08M
Ending Cash Balance
6.63M14.05M10.35M12.12M7.14M6.89M6.92M5.72M2.64M2.82M1.20M0.88M4.36M2.34M0.75M2.07M1.72M0.60M10.27M4.20M
Free Cash FlowFCF
-1.93M-2.05M-1.97M-1.70M-2.29M-2.19M-1.62M-1.80M-2.60M-2.94M-2.06M-0.78M-2.57M-1.60M-0.51M-3.50M-2.91M-1.19M-5.03M
Net Cash FlowNCF
7.46M-1.80M1.89M-4.78M-0.36M0.01M-1.22M-3.10M0.18M-1.62M-0.31M3.47M-2.01M-1.60M1.30M-0.30M-1.12M9.67M-6.10M
Interest Paid

Artelo Biosciences Cash Flow Statement API

Pull Artelo Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ARTL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY